These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 21123490
1. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling. Yuan Y, Zhang A, Huang S, Ding G, Chen R. Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490 [Abstract] [Full Text] [Related]
2. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation. Huang S, Zhang A, Ding G, Chen R. Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632 [Abstract] [Full Text] [Related]
3. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma. Li X, Yang X, Xu Y, Jiang X, Li X, Nan F, Tang H. Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774 [Abstract] [Full Text] [Related]
4. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Chen A, Xu J. Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348 [Abstract] [Full Text] [Related]
5. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Tencer L, Burgermeister E, Ebert MP, Liscovitch M. Anticancer Res; 2008 Mar; 28(2A):895-906. PubMed ID: 18507034 [Abstract] [Full Text] [Related]
6. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells. Zhu H, Pan X, Qi H, Wang X, Hou S, Han B, Liu Z, Xu L. Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961 [Abstract] [Full Text] [Related]
7. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Kim KY, Ahn JH, Cheon HG. Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976 [Abstract] [Full Text] [Related]
8. ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways. Heo JS, Han HJ. Stem Cells; 2006 Dec; 24(12):2637-48. PubMed ID: 16916926 [Abstract] [Full Text] [Related]
9. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells. Chen KC, Zhou Y, Zhang W, Lou MF. Mol Vis; 2007 Mar 14; 13():374-87. PubMed ID: 17392688 [Abstract] [Full Text] [Related]
10. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP. Int J Oncol; 2004 Aug 14; 25(2):493-502. PubMed ID: 15254749 [Abstract] [Full Text] [Related]
11. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. Varley CL, Stahlschmidt J, Lee WC, Holder J, Diggle C, Selby PJ, Trejdosiewicz LK, Southgate J. J Cell Sci; 2004 Apr 15; 117(Pt 10):2029-36. PubMed ID: 15054105 [Abstract] [Full Text] [Related]
12. Caveolin-1 phosphorylation is required for stretch-induced EGFR and Akt activation in mesangial cells. Zhang B, Peng F, Wu D, Ingram AJ, Gao B, Krepinsky JC. Cell Signal; 2007 Aug 15; 19(8):1690-700. PubMed ID: 17446044 [Abstract] [Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS, Chen WC, Bai X, Wang YD. J Dig Dis; 2007 May 15; 8(2):82-8. PubMed ID: 17532820 [Abstract] [Full Text] [Related]
14. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells. Kim HJ, Woo IS, Kang ES, Eun SY, Kim GH, Ham SA, Kim HJ, Lee JH, Chang KC, Kim JH, Lee HT, Seo HG. Biochem Biophys Res Commun; 2006 Oct 20; 349(2):660-7. PubMed ID: 16945329 [Abstract] [Full Text] [Related]
15. Requirement of the epidermal growth factor receptor in renal epithelial cell proliferation and migration. Zhuang S, Dang Y, Schnellmann RG. Am J Physiol Renal Physiol; 2004 Sep 20; 287(3):F365-72. PubMed ID: 15213065 [Abstract] [Full Text] [Related]
16. Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia-reperfusion in SK-N-SH cells. Kim KY, Cho HS, Lee SH, Ahn JH, Cheon HG. Brain Res; 2011 Feb 04; 1372():103-14. PubMed ID: 21111719 [Abstract] [Full Text] [Related]
17. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway. Díaz-Delfín J, Morales M, Caelles C. Diabetes; 2007 Jul 04; 56(7):1865-71. PubMed ID: 17416798 [Abstract] [Full Text] [Related]
18. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M, Wolf G. Am J Nephrol; 2007 Jul 04; 27(4):425-34. PubMed ID: 17622750 [Abstract] [Full Text] [Related]
19. ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. Ding G, Zhang A, Huang S, Pan X, Zhen G, Chen R, Yang T. Am J Physiol Renal Physiol; 2007 Dec 04; 293(6):F1889-97. PubMed ID: 17881465 [Abstract] [Full Text] [Related]
20. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells. Uttarwar L, Gao B, Ingram AJ, Krepinsky JC. Am J Physiol Renal Physiol; 2012 Feb 01; 302(3):F329-41. PubMed ID: 22031849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]